Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms-Reference-Cited by-同舟云学术

Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms

Published:2010-11 Issue:3 Volume:53 Page:483-489
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Krishnaiah Ch.,Reddy A. Raghupathi,Kumar Ramesh,Mukkanti K.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference16 articles.

1. Development and validation of chiral high-performance liquid chromatographic methods for the quantitation of valsartan and of the tosylate of valinebenzyl ester;Francotte;J. Chromatogr. B: Biomed. Appl.,1996

2. Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection;Piao;Arch. Pharm. Res.,2008

3. Biovalidation of an SPE–HPLC–UV-fluorescence method for the determination of valsartan and its metabolite valeryl-4-hydroxy-valsartan in human plasma;Iriarte;J. Sep. Sci.,2007

4. Identification and characterization of potential impurities of valsartan AT1 receptor antagonist;Sampath;J. Pharm. Biomed. Anal.,2009

5. Determination of ecabet in human plasma by high-performance liquid chromatography–tandem mass spectrometry;Zhang;J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.,2008

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method Development and Validation of Valsartan by Using Stability-Indicating RP-HPLC Method;Advances in Pharmacology and Pharmacy;2024-10

2. Development and Validation of Simultaneous Quantitative Dissolution Analysis for the Two Active Pharmaceutical Ingredients in Dapagliflozin Propanediol Monohydrate-sitagliptin Phosphate Monohydrate Multi-layered Tablets;Current Pharmaceutical Analysis;2023-12

3. Spectroscopic and Chromatographic Estimation of Some Sartans and their Combinations with Thiazide Diuretics: A Review;Current Pharmaceutical Analysis;2023-10

4. Formulation, in-vitro evaluation and optimization of valsartan nano- lipid complex by Box-Behnken design;PAK J PHARM SCI;2023

5. АНАЛІТИЧНІ МЕТОДИКИ ВИЗНАЧЕННЯ ВАЛСАРТАНУ В ЛІКАРСЬКИХ ЗАСОБАХ;Medical and Clinical Chemistry;2023-04-27